Skip to main content

Advertisement

Log in

Familial Early-Onset Paget’s Disease of Bone Associated with a Novel hnRNPA2B1 Mutation

  • Original Research
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Paget disease of bone (PDB) is a common metabolic bone disease characterized by increased bone resorption and disorganized bone formation which affect single or multiple sites of bones. Although the exact cause of PDB is still controversial, genetic factors are considered to play an important role in PDB. Several genes involved in the differentiation or function of osteoclast were shown to be associated with PDB or related syndrome such as SQSTM1, TNFRSF11A, TNFRSF11B, and ZNF687. Multisystem proteinopathy (MSP), a newly proposed syndrome including inclusion body myopathy (IBM), PDB, frontotemporal dementia (FTD), and amyotrophic lateral sclerosis (ALS), is mainly caused by mutation in VCP gene. In 2013, a new casual gene for MSP was identified as hnRNPA2B1 gene. This may partly account for the inherited PDB traits which is however negative for mutation in already known causative PDB genes. We investigated a Chinese family with multiple affected individuals with PDB, but none of the members showed symptoms of IBM, FTD, or ALS. Three patients were evaluated clinically, biochemically, and radiographically. To screen for the responsible mutation, whole-exome sequencing was conducted in the proband, another patient, as well as a normal individual from the family. This revealed a novel heterozygous missense mutation of hnRNPA2B1 gene (c.929C>T, p. P310L) in the two patients which was then verified in all affected individuals. We describe here a novel missense mutation in hnRNPA2B1 gene in a large pedigree affected with PDB with members who do not present other manifestations of multisystem proteinopathy, such as IBM, FTD, and ALS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Paget J (1877) On a form of chronic inflammation of bones (osteitis deformans). Med Chir Trans 60:37–64

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Falchetti A, Masi L, Brandi ML (2010) Paget’s disease of bone: there’s more than the affected skeletal–a clinical review and suggestions for the clinical practice. Curr Opin Rheumatol 22:410–423

    Article  PubMed  Google Scholar 

  3. van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Cooper C (2002) Incidence and natural history of Paget’s disease of bone in England and Wales. J Bone Miner Res 17:465–471

    Article  PubMed  Google Scholar 

  4. Poor G, Donath J, Fornet B, Cooper C (2006) Epidemiology of Paget’s disease in Europe: the prevalence is decreasing. J Bone Miner Res 21:1545–1549

    Article  PubMed  Google Scholar 

  5. Griz L, Caldas G, Bandeira C, Assuncao V, Bandeira F (2006) Paget’s disease of bone. Arq Bras Endocrinol Metabol 50:814–822

    Article  PubMed  Google Scholar 

  6. Tiegs RD, Lohse CM, Wollan PC, Melton LJ (2000) Long-term trends in the incidence of Paget’s disease of bone. Bone 27:423–427

    Article  CAS  PubMed  Google Scholar 

  7. Shaker JL (2009) paget’s disease of bone: a review of epidemiology, pathophysiology and management. Ther Adv Musculoskelet Dis 1:107–125

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Galson DL, Roodman GD (2014) Pathobiology of Paget’s disease of bone. J Bone Metab 21:85–98

    Article  PubMed  PubMed Central  Google Scholar 

  9. Ralston SH, Albagha OM (2014) Genetics of Paget’s disease of bone. Curr Osteoporos Rep 12:263–271

    Article  PubMed  Google Scholar 

  10. Divisato G, Formicola D, Esposito T, Merlotti D, Pazzaglia L, Del FA, Siris E, Orcel P, Brown JP, Nuti R, Strazzullo P, Benassi MS, Cancela ML, Michou L, Rendina D, Gennari L, Gianfrancesco F (2016) ZNF687 mutations in severe Paget disease of bone associated with giant cell tumor. Am J Hum Genet 98:275–286

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36:377–381

    Article  CAS  PubMed  Google Scholar 

  12. Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, Diaz Z, MacLea KS, Freibaum B, Li S, Molliex A, Kanagaraj AP, Carter R, Boylan KB, Wojtas AM, Rademakers R, Pinkus JL, Greenberg SA, Trojanowski JQ, Traynor BJ, Smith BN, Topp S, Gkazi AS, Miller J, Shaw CE, Kottlors M, Kirschner J, Pestronk A, Li YR, Ford AF, Gitler AD, Benatar M, King OD, Kimonis VE, Ross ED, Weihl CC, Shorter J, Taylor JP (2013) Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495:467–473

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Ralston SH (2013) Clinical practice. Paget’s disease of bone. N Engl J Med 368:644–650

    Article  CAS  PubMed  Google Scholar 

  14. Liu G, Wei X, Chen R, Zhou H, Li X, Sun Y, Xie S, Zhu Q, Qu N, Yang G, Chu Y, Wu H, Lan Z, Wang J, Yang Y, Yi X (2014) A novel mutation of the SLC25A13 gene in a Chinese patient with citrin deficiency detected by target next-generation sequencing. Gene 533:547–553

    Article  CAS  PubMed  Google Scholar 

  15. Asan, Xu Y, Jiang H, Tyler-Smith C, Xue Y, Jiang T, Wang J, Wu M, Liu X, Tian G, Wang J, Wang J, Yang H, Zhang X (2011) Comprehensive comparison of three commercial human whole-exome capture platforms. Genome Biol 12:R95

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Wei X, Ju X, Yi X, Zhu Q, Qu N, Liu T, Chen Y, Jiang H, Yang G, Zhen R, Lan Z, Qi M, Wang J, Yang Y, Chu Y, Li X, Guang Y, Huang J (2011) Identification of sequence variants in genetic disease-causing genes using targeted next-generation sequencing. PLoS ONE 6:e29500

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Clarkson JG (1991) Paget’s disease and angioid streaks: one complication less? Br J Ophthalmol 75:511

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Reva B, Antipin Y, Sander C (2011) Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res 39:e118

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Alberti S, Halfmann R, King O, Kapila A, Lindquist S (2009) A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 137:146–158

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM, Baralle FE (2005) TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem 280:37572–37584

    Article  CAS  PubMed  Google Scholar 

  21. Xiang S, Kato M, Wu LC, Lin Y, Ding M, Zhang Y, Yu Y, McKnight SL (2015) The LC Domain of hnRNPA2 adopts similar conformations in hydrogel polymers, liquid-like droplets, and nuclei. Cell 163:829–839

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Ralston SH, Langston AL, Reid IR (2008) Pathogenesis and management of Paget’s disease of bone. The Lancet 372:155–163

    Article  CAS  Google Scholar 

  23. Shankar S, Hosking DJ (2006) Biochemical assessment of Paget’s disease of bone. J Bone Miner Res 21(Suppl 2):P22–P27

    Article  CAS  PubMed  Google Scholar 

  24. Garnero P, Fledelius C, Gineyts E, Serre CM, Vignot E, Delmas PD (1997) Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget’s disease of bone. J Bone Miner Res 12:1407–1415

    Article  CAS  PubMed  Google Scholar 

  25. Cundy T, Rutland MD, Naot D, Bolland M (2015) Evolution of Paget’s disease of bone in adults inheriting SQSTM1 mutations. Clin Endocrinol (Oxf) 83:315–319

    Article  CAS  Google Scholar 

  26. Morissette J, Laurin N, Brown JP (2006) Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget’s disease of bone. J Bone Miner Res 21(Suppl 2):P38–P44

    Article  CAS  PubMed  Google Scholar 

  27. Bolland MJ, Tong PC, Naot D, Callon KE, Wattie DJ, Gamble GD, Cundy T (2007) Delayed development of Paget’s disease in offspring inheriting SQSTM1 mutations. J Bone Miner Res 22:411–415

    Article  CAS  PubMed  Google Scholar 

  28. Kimonis VE, Mehta SG, Fulchiero EC, Thomasova D, Pasquali M, Boycott K, Neilan EG, Kartashov A, Forman MS, Tucker S, Kimonis K, Mumm S, Whyte MP, Smith CD, Watts GD (2008) Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. Am J Med Genet A 146A:745–757

    Article  PubMed  PubMed Central  Google Scholar 

  29. Calini D, Corrado L, Del BR, Gagliardi S, Pensato V, Verde F, Corti S, Mazzini L, Milani P, Castellotti B, Bertolin C, Soraru G, Cereda C, Comi GP, D’Alfonso S, Gellera C, Ticozzi N, Landers JE, Ratti A, Silani V (2013) Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis. Neurobiol Aging 34:2611–2695

    Article  Google Scholar 

  30. Le Ber I, Van Bortel I, Nicolas G, Bouya-Ahmed K, Camuzat A, Wallon D, De Septenville A, Latouche M, Lattante S, Kabashi E, Jornea L, Hannequin D, Brice A (2014) hnRNPA2B1 and hnRNPA1 mutations are rare in patients with “multisystem proteinopathy” and frontotemporal lobar degeneration phenotypes. Neurobiol Aging 35:934–935

    PubMed  Google Scholar 

  31. Seelen M, Visser AE, Overste DJ, Kim HJ, Palud A, Wong TH, van Swieten JC, Scheltens P, Voermans NC, Baas F, de Jong JM, van der Kooi AJ, de Visser M, Veldink JH, Taylor JP, Van Es MA, van den Berg LH (2014) No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy. Neurobiol Aging 35:1956–1959

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We appreciate our patient and his family for their participation in this study. This study was supported by a grant from The Ministry of Science and Technology of the People’s Republic of China (National Science and Technology Major Projects for “Major New Drugs Innovation and Development” 2008ZX09312-016), the National Natural Science Foundation of China (No.81070687 and 81170805), Beijing Natural Science Foundation (No. 7121012), and Scientific Research Foundation of Beijing Medical Development (No. 2007-3029). National Key Program of Clinical Science (WBYZ2011-873). Dr. Xuan Qi and Qianqian Pang designed the study and prepared the first draft of the paper. Dr. Qianqian Pang contributed to the experimental work. Dr. Xuan Qi was responsible for statistical analysis of the data. All listed authors revised the paper critically for intellectual content and approved the final version of the submitted manuscript. All authors agree to be accountable for the work and to ensure that any questions relating to the accuracy and integrity of the paper are investigated and properly resolved.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Asan or Weibo Xia.

Ethics declarations

Conflict of interest

Xuan Qi, Qianqian Pang, Jiawei Wang, Zhen Zhao, Ou Wang, Lijun Xu, Jiangfeng Mao, Yan Jiang, Mei Li, Xiaoping Xing, Wei Yu, Asan, Weibo Xia state that they have no conflicts of interest.

Human and Animal Rights

The study was conducted in accordance with the ethics principles of the Declaration of Helsinki and was approved by the ethics committee of PUMCH.

Informed Consent

All participants gave written informed consent for the study.

Additional information

Xuan Qi and Qianqian Pang have equally contributed to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (TIF 1664 KB)

223_2017_269_MOESM2_ESM.docx

Supplementary Figure 1—Align with templates and quality inspection of the hnRNPA2B1 three dimensional (3D) structured (ad): a the target amino acid sequence of hnRNPA2B1 was aligned with the sequence of 1 × 4B, 2UP1 and 2H4M. bd Quality inspection of the hnRNPA2B1 protein model by ERRAT (b), Verify 3D (c) and Ramachandran plot (d). (DOCX 18 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qi, X., Pang, Q., Wang, J. et al. Familial Early-Onset Paget’s Disease of Bone Associated with a Novel hnRNPA2B1 Mutation. Calcif Tissue Int 101, 159–169 (2017). https://doi.org/10.1007/s00223-017-0269-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-017-0269-0

Keywords

Navigation